Clinical considerations of lipid target and goal in dyslipidemia control
Enregistré dans:
Auteurs principaux: | Na-Qiong Wu, Jian-Jun Li |
---|---|
Format: | article |
Langue: | EN |
Publié: |
KeAi Communications Co., Ltd.
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/02fa1ca9ad874cf6843bde9bc9135bc5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
par: Hirotaka Fukami, et autres
Publié: (2021) -
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
par: Frustaci AM, et autres
Publié: (2015) -
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
par: Wang L, et autres
Publié: (2012) -
Allium sativum, Hylocereus polyrhizus and its Combination Effectiveness on Lipid Profiles and Number of Foam Cells in Rats with Dyslipidemia
par: Wipi Sari Aisah, et autres
Publié: (2019) -
New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China
par: Da-Yi Hu
Publié: (2017)